Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$76.67 - $87.62 $11.1 Million - $12.7 Million
144,400 New
144,400 $11.3 Million
Q4 2023

Feb 14, 2024

BUY
$61.89 - $69.28 $5.07 Million - $5.67 Million
81,900 New
81,900 $5.52 Million
Q1 2023

May 15, 2023

BUY
$63.15 - $71.6 $7.11 Million - $8.06 Million
112,550 New
112,550 $7.81 Million
Q3 2022

Nov 15, 2022

BUY
$53.02 - $135.75 $2.57 Million - $6.59 Million
48,550 New
48,550 $2.66 Million

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $200B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.